Madalena M. M. Pinto

Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy

F. Carvalho, E. Sousa, M. Pinto, 2016, Archives of Toxicology.